Literature DB >> 12940463

A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland.

Nobuhiro Miyamura1, Atsuyuki Tsutsumi, Hiroko Senokuchi, Kazuhiko Nakamaru, Junji Kawashima, Kohji Sakai, Tetsuya Taguchi, Hiroshi Tokunaga, Kenro Nishida, Masaya Uehara, Michiharu Sakakida, Eiichi Araki.   

Abstract

ACTH-independent macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing's syndrome. Recently, aberrant expression of adrenal receptors for various hormones and/or cytokines has been identified in several cases with AIMAH, which may act as a pathogenetic factor for the disorder. We report here an AIMAH patient with a Rathke's cleft cyst. Endocrinological examinations revealed that the pituitary cyst had no hormonal secretion. Administrations of either AVP or isoproterenol provoked cortisol production in the patient, whereas DDAVP, mosapride or endogenous LH induced by GnRH did not. Reverse transcriptional-PCR analysis of total RNA obtained from the patient's adrenal tissue revealed the expression of mRNA of receptors for V1a, V1b, V2, and LH/hCG. Three of these receptors except for V1a receptor were not expressed in normal adrenal tissue. Hyperosmolar saline infusion promoted the patient's cortisol secretion through the increase in endogenous AVP (peak plasma AVP level reached 90.4 pg/ml during the test). These results suggest that endogenous AVP and catecholamines are involved in the pathophysiology of the patient. Further study will be necessary to clarify the molecular mechanisms that regulate tissue-specific expression of these receptors and their role in the overgrowth of adrenal in AIMAH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940463     DOI: 10.1507/endocrj.50.333

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

Review 1.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

2.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

3.  Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.

Authors:  Kenji Oki; Kiminori Yamane; Shuhei Nakanishi; Reiko Nakashima; Kuniaki Jitsuiki; Nobuoki Kohno
Journal:  Endocrine       Date:  2009-10-08       Impact factor: 3.633

4.  Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia.

Authors:  Jie Zhu; Liang Cui; Wei Wang; Xing-Yi Hang; A-Xiang Xu; Su-Xia Yang; Jing-Tao Dou; Yi-Ming Mu; Xu Zhang; Jiang-Ping Gao
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

5.  [Cushing's syndrome with bilateral nodular adrenal enlargement].

Authors:  M op den Winkel; C J Auernhammer; K W Jauch; G Assmann; C Dietz; K G Parhofer
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

6.  Alterations of DNA methylation were associated with the rapid growth of cortisol-producing adrenocortical adenoma during pregnancy.

Authors:  Chuan Wang; Yujing Sun; Xiaofei Yin; Ruoqi Feng; Ruiying Feng; Mingyue Xu; Kai Liang; Ruxing Zhao; Gangli Gu; Xuewen Jiang; Peng Su; Xiaofang Zhang; Jinbo Liu
Journal:  Clin Epigenetics       Date:  2021-12-04       Impact factor: 6.551

7.  Effect of ACTH and hCG on the Expression of Gonadotropin-Inducible Ovarian Transcription Factor 1 (Giot1) Gene in the Rat Adrenal Gland.

Authors:  Karol Jopek; Marianna Tyczewska; Manjunath Ramanjaneya; Marta Szyszka; Piotr Celichowski; Paulina Milecka; Ludwik K Malendowicz; Marcin Rucinski
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.